Browse Items (8 total)
- Tags: Pneumonia – Drug Therapy
A new perspective.
Tags: *Attitude of Health Personnel, *Hospitalists, *Internship and Residency, 2009, Anti-Bacterial Agents/therapeutic use, Antibiotics – Therapeutic Use, Attitude of Health Personnel, Duggal Abhijit, Emergency Service, Emergency Service – Administration, Hospital/*organization & administration, Hospitalists, Humans, Internship and Residency, Journal of hospital medicine, Pneumonia – Diagnosis, Pneumonia – Drug Therapy, Pneumonia/diagnosis/*drug therapy
Community-acquired pneumonia: recent guidelines for therapy.
A new dosing paradigm: high-dose, short-course fluoroquinolone therapy for community-acquired pneumonia.
Tags: 2003, Antiinfective Agents, Clinical cornerstone, Department of Internal Medicine, File T M Jr, Fluoroquinolone, Fluoroquinolone – Administration and Dosage, Fluoroquinolone – Economics, Fluoroquinolone – Pharmacodynamics, Fluoroquinolone – Therapeutic Use, NEOMED College of Medicine, Pneumonia – Drug Therapy
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
Tags: 2004, Antibiotics, Bacteria – Drug Effects, Benninger MS, Clinics in laboratory medicine, Combined – Therapeutic Use, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Jacobs MR, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Rhinosinusitis – Drug Therapy, Rhinosinusitis – Microbiology
Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
Tags: 2004, Adult, Chi Square Test, Community-Acquired Infections – Drug Therapy, Current Medical Research & Opinion, Department of Internal Medicine, Double-Blind Studies, Female, File T M Jr, Funding Source, Human, Kaplan-Meier Estimator, Khashab MM, Log-Rank Test, Male, McNemar's Test, Milkovich G, NEOMED College of Medicine, Ofloxacin – Administration and Dosage, Pneumonia – Drug Therapy, Random Assignment, Retrospective Design, T-Tests, Tennenberg AM, Xiang JX, Zadeikis N
International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
Tags: 2003, Antibiotics, Clinical Trials, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Etiology, Department of Internal Medicine, Drug Resistance, Drugs, File T M Jr, Immune System – Drug Effects, Inpatients, Macrolide – Pharmacodynamics, Macrolide – Therapeutic Use, Methicillin Resistance, Microbial, NEOMED College of Medicine, Nonexperimental Studies, Outpatients, Pneumonia – Drug Therapy, Pneumonia – Etiology, Practice Guidelines, Risk Assessment, Streptococcal Infections – Drug Therapy, Tan J S
Case studies of lower respiratory tract infections: community-acquired pneumonia.
Tags: 2010, Acute – Microbiology, Adult, Adult/microbiology, Aged, Anti-Bacterial Agents/*therapeutic use, Antibiotics – Therapeutic Use, Antitubercular Agents – Therapeutic Use, Antitubercular Agents/therapeutic use, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections/diagnosis/drug therapy, Cough, Cough – Microbiology, Cough/microbiology/virology, Department of Internal Medicine, Diagnosis, Differential, Dyspnea, Fatal Outcome, Female, Fever – Microbiology, Fever/microbiology, File Thomas M Jr, Hemoptysis – Microbiology, Hemoptysis/microbiology, Human, Human – Complications, Human – Diagnosis, Human/complications/*diagnosis, Humans, Hypotension – Microbiology, Hypotension/microbiology, Influenza, Leukopenia – Microbiology, Leukopenia/microbiology, Male, Methicillin-Resistant Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus/*isolation & purification, Miliary/diagnosis/drug therapy, Multiple Organ Dysfunction Syndrome – Microbiology, Multiple Organ Failure/microbiology, Mycobacterium Tuberculosis, Mycobacterium tuberculosis/isolation & purification, NEOMED College of Medicine, Pneumonia – Diagnosis, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Pneumonia – Therapy, Pneumonia/*diagnosis/*drug therapy/microbiology/therapy, Practice Guidelines, Practice Guidelines as Topic, Respiratory Distress Syndrome, Risk Factors, Severity of Illness Index, Severity of Illness Indices, Smoking, Smoking/adverse effects, Staphylococcal Infections – Diagnosis, Staphylococcal Infections – Drug Therapy, Staphylococcal Infections – Microbiology, Staphylococcal Infections – Therapy, Staphylococcal Infections/*diagnosis/*drug therapy/microbiology/therapy, The American journal of medicine, Tuberculosis, Tuberculosis – Diagnosis, Tuberculosis – Drug Therapy
Does empiric therapy for atypical pathogens improve outcomes for patients with CAP?
Tags: 2013, Anti-Bacterial Agents/*therapeutic use, Antibiotic Prophylaxis, Antibiotics – Therapeutic Use, Clinical Trials, Clinical Trials as Topic, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, File Thomas M Jr, Humans, Infectious disease clinics of North America, Marrie Thomas J, NEOMED College of Medicine, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Pneumonia/*drug therapy/microbiology